Literature DB >> 15084146

Crystal structure of NS-134 in complex with bovine cathepsin B: a two-headed epoxysuccinyl inhibitor extends along the entire active-site cleft.

Igor Stern1, Norbert Schaschke, Luis Moroder, Dusan Turk.   

Abstract

The crystal structure of the inhibitor NS-134 in complex with bovine cathepsin B reveals that functional groups attached to both sides of the epoxysuccinyl reactive group bind to the part of active-site cleft as predicted. The -Leu-Pro-OH side binds to the primed binding sites interacting with the His110 and His111 residues with its C-terminal carboxy group, whereas the -Leu-Gly-Meu (-Leu-Gly-Gly-OMe) part (Meu, methoxycarbonylmethyl) binds along the non-primed binding sites. Comparison with the propeptide structures of cathepsins revealed that the binding of the latter part is least similar to the procathepsin B structure; this result, together with the two-residue shift in positioning of the Leu-Gly-Gly part, suggests that the propeptide structures of the cognate enzymes may not be the best starting point for the design of reverse binding inhibitors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15084146      PMCID: PMC1133859          DOI: 10.1042/BJ20040237

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  42 in total

1.  Crystal structure of human procathepsin X: a cysteine protease with the proregion covalently linked to the active site cysteine.

Authors:  J Sivaraman; D K Nägler; R Zhang; R Ménard; M Cygler
Journal:  J Mol Biol       Date:  2000-01-28       Impact factor: 5.469

2.  Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons.

Authors:  A Nicholls; K A Sharp; B Honig
Journal:  Proteins       Date:  1991

3.  Design of potent and selective human cathepsin K inhibitors that span the active site.

Authors:  S K Thompson; S M Halbert; M J Bossard; T A Tomaszek; M A Levy; B Zhao; W W Smith; S S Abdel-Meguid; C A Janson; K J D'Alessio; M S McQueney; B Y Amegadzie; C R Hanning; R L DesJarlais; J Briand; S K Sarkar; M J Huddleston; C F Ijames; S A Carr; K T Garnes; A Shu; J R Heys; J Bradbeer; D Zembryki; L Lee-Rykaczewski; I E James; M W Lark; F H Drake; M Gowen; J G Gleason; D F Veber
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

4.  Binding mode of CA074, a specific irreversible inhibitor, to bovine cathepsin B as determined by X-ray crystal analysis of the complex.

Authors:  A Yamamoto; T Hara; K Tomoo; T Ishida; T Fujii; Y Hata; M Murata; K Kitamura
Journal:  J Biochem       Date:  1997-05       Impact factor: 3.387

5.  Increased expression of mature cathepsin B in aging rat liver.

Authors:  D Keppler; R Walter; C Pérez; F Sierra
Journal:  Cell Tissue Res       Date:  2000-11       Impact factor: 5.249

6.  Novel epoxysuccinyl peptides. Selective inhibitors of cathepsin B, in vitro.

Authors:  M Murata; S Miyashita; C Yokoo; M Tamai; K Hanada; K Hatayama; T Towatari; T Nikawa; N Katunuma
Journal:  FEBS Lett       Date:  1991-03-25       Impact factor: 4.124

7.  On the size of the active site in proteases. I. Papain.

Authors:  I Schechter; A Berger
Journal:  Biochem Biophys Res Commun       Date:  1967-04-20       Impact factor: 3.575

8.  E-64 analogues as inhibitors of cathepsin B. On the role of the absolute configuration of the epoxysuccinyl group.

Authors:  N Schaschke; I Assfalg-Machleidt; W Machleidt; D Turk; L Moroder
Journal:  Bioorg Med Chem       Date:  1997-09       Impact factor: 3.641

9.  Cathepsin B in osteoblasts.

Authors:  Maria Cristina Aisa; Tommaso Beccari; Egidia Costanzi; Dario Maggio
Journal:  Biochim Biophys Acta       Date:  2003-05-02

10.  Surface cathepsin B protects cytotoxic lymphocytes from self-destruction after degranulation.

Authors:  Kithiganahalli N Balaji; Norbert Schaschke; Werner Machleidt; Marta Catalfamo; Pierre A Henkart
Journal:  J Exp Med       Date:  2002-08-19       Impact factor: 14.307

View more
  8 in total

1.  Targeting Cathepsin B for Cancer Therapies.

Authors:  Hang Ruan; Susan Hao; Peter Young; Hongtao Zhang
Journal:  Horiz Cancer Res       Date:  2015 2nd Quarter

Review 2.  The cathepsins contribute to life and death in the placenta.

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2006-03-24       Impact factor: 4.599

3.  Recombinant expression, characterization and expressional analysis of clam Meretrix meretrix cathepsin B, an enzyme involved in nutrient digestion.

Authors:  Xueliang Yao; Jiquan Zhang; Jinsheng Sun; Baozhong Liu
Journal:  Mol Biol Rep       Date:  2010-09-19       Impact factor: 2.316

4.  Catch and Release Photosensitizers: Combining Dual-Action Ruthenium Complexes with Protease Inactivation for Targeting Invasive Cancers.

Authors:  Karan Arora; Mackenzie Herroon; Malik H Al-Afyouni; Nicholas P Toupin; Thomas N Rohrabaugh; Lauren M Loftus; Izabela Podgorski; Claudia Turro; Jeremy J Kodanko
Journal:  J Am Chem Soc       Date:  2018-10-22       Impact factor: 15.419

5.  Collagenolytic activities of the major secreted cathepsin L peptidases involved in the virulence of the helminth pathogen, Fasciola hepatica.

Authors:  Mark W Robinson; Ileana Corvo; Peter M Jones; Anthony M George; Matthew P Padula; Joyce To; Martin Cancela; Gabriel Rinaldi; Jose F Tort; Leda Roche; John P Dalton
Journal:  PLoS Negl Trop Dis       Date:  2011-04-05

Review 6.  Cysteine cathepsins: from structure, function and regulation to new frontiers.

Authors:  Vito Turk; Veronika Stoka; Olga Vasiljeva; Miha Renko; Tao Sun; Boris Turk; Dušan Turk
Journal:  Biochim Biophys Acta       Date:  2011-10-12

7.  Selective targeting of tumor and stromal cells by a nanocarrier system displaying lipidated cathepsin B inhibitor.

Authors:  G Mikhaylov; D Klimpel; N Schaschke; U Mikac; M Vizovisek; M Fonovic; V Turk; Boris Turk; Olga Vasiljeva
Journal:  Angew Chem Int Ed Engl       Date:  2014-06-27       Impact factor: 15.336

8.  Foot-and-mouth disease virus leader proteinase: structural insights into the mechanism of intermolecular cleavage.

Authors:  Jutta Steinberger; Irina Grishkovskaya; Regina Cencic; Luiz Juliano; Maria A Juliano; Tim Skern
Journal:  Virology       Date:  2014-09-19       Impact factor: 3.616

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.